Antitumor effect of FP3 in combination with cetuximab on patient-derived tumor tissue xenograft models of primary colon carcinoma and related lymphatic and hepatic metastases

Author：                      

Publisher： Spandidos Publications

ISSN： 1107-3756

Source： International Journal of Molecular Medicine, Vol.30, Iss.1, 2012-01, pp. : 126-132

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Personalized cancer therapy using a patient-derived tumor tissue xenograft model: a translational field worthy of exploring further?

By Jin Ketao   He Kuifeng   Li Guangliang   Teng Lisong  

Personalized Medicine, Vol. 7, Iss. 5, 2010-09 ,pp. : 597-606

Future Medicine

Access to resources Recommend Favorite

Potent antitumor activity of cabozantinib, a c‐MET and VEGFR2 inhibitor, in a colorectal cancer patient‐derived tumor explant model

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 136, Iss. 8, 2015-04 ,pp. : 1967-1975

John Wiley & Sons Inc

Access to resources Recommend Favorite

Antitumor Effect of Everolimus in a Patient with Type 3 Gastric Neuroendocrine Tumor

By  

Oncology Research and Treatment, Vol. 36, Iss. 9, 2013-08 ,pp. : 502-504

Karger

Access to resources Recommend Favorite

Effective Second-Line Treatment with Cetuximab and Bevacizumab in a Patient with Hepatic Metastases of Colorectal Cancer and Hyperbilirubinemia

By  

Oncology Research and Treatment, Vol. 30, Iss. 10, 2007-09 ,pp. : 509-512

Karger

Access to resources Recommend Favorite

Generation of pediatric liver cancer patient–derived xenograft platforms for pediatric liver cancer: A critical stage in the development of anticancer treatments

By  

HEPATOLOGY, Vol. 64, Iss. 4, 2016-10 ,pp. : 1017-1019

John Wiley & Sons Inc

Access to resources Recommend Favorite